Open AccessCOVID-19: EPIDEMIOLOGY, PATHOGENICITY AND GLOBAL UPDATES
Author(s) -
Manjinder Singh,
Manju Nagpal,
Varinder Singh,
Ameya Sharma,
Gitika Arora Dhingra,
Paramjot Maman,
Vivek Puri
Publication year - 2020
Publication title -
international journal of applied pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 15
ISSN - 0975-7058
DOI - 10.22159/ijap.2020v12i5.38439
Subject(s) - pandemic , epidemiology , covid-19 , pathogenicity , clinical trial , medicine , intensive care medicine , outbreak , transmission (telecommunications) , disease , virology , biology , computer science , infectious disease (medical specialty) , pathology , telecommunications , microbiology and biotechnology
Novel coronavirus (COVID-19) is a highly contagious virus that originated from China and has become a major threat in the current time. Presently, finding an effective treatment strategy for COVID-19 is in infancy. Worldwide, numerous clinical trials employing different treatment strategies (antiviral drugs and vaccines) are in progress to develop an effective therapeutic regimen against COVID-19. Literature related to the epidemiology, mortality, pathogenicity, treatment strategies and clinical data was studied and database was collected using various search engines such as j-gate, google scholar, scihub, pubmed, sciencedirect etc. The present review systematically summarises the published information about epidemiology, various stages of pandemic, mortality, pathogenicity, modes of transmission, clinical characteristics, methods of prevention, ongoing treatment strategies and drugs under clinical trials associated with COVID-19 with a hope to avoid possible threatening of the lives of millions of human beings and provide directions for future studies.